- Home
- SWVL vs ANVS Comparison
SWVL vs ANVS Comparison
Compare SWVL & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWVL
- ANVS
- Stock Information
- Founded
- SWVL 2017
- ANVS 2008
- Country
- SWVL United Arab Emirates
- ANVS United States
- Employees
- SWVL N/A
- ANVS N/A
- Industry
- SWVL Business Services
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- SWVL Consumer Discretionary
- ANVS Health Care
- Exchange
- SWVL Nasdaq
- ANVS Nasdaq
- Market Cap
- SWVL 44.5M
- ANVS 44.6M
- IPO Year
- SWVL N/A
- ANVS 2020
- Fundamental
- Price
- SWVL $4.75
- ANVS $2.75
- Analyst Decision
- SWVL
- ANVS Strong Buy
- Analyst Count
- SWVL 0
- ANVS 4
- Target Price
- SWVL N/A
- ANVS $18.00
- AVG Volume (30 Days)
- SWVL 22.5K
- ANVS 442.5K
- Earning Date
- SWVL 07-22-2025
- ANVS 08-14-2025
- Dividend Yield
- SWVL N/A
- ANVS N/A
- EPS Growth
- SWVL N/A
- ANVS N/A
- EPS
- SWVL N/A
- ANVS N/A
- Revenue
- SWVL $17,207,362.00
- ANVS N/A
- Revenue This Year
- SWVL N/A
- ANVS N/A
- Revenue Next Year
- SWVL N/A
- ANVS N/A
- P/E Ratio
- SWVL N/A
- ANVS N/A
- Revenue Growth
- SWVL N/A
- ANVS N/A
- 52 Week Low
- SWVL $2.40
- ANVS $1.11
- 52 Week High
- SWVL $8.05
- ANVS $14.80
- Technical
- Relative Strength Index (RSI)
- SWVL 63.96
- ANVS 57.81
- Support Level
- SWVL $3.87
- ANVS $2.24
- Resistance Level
- SWVL $4.67
- ANVS $2.97
- Average True Range (ATR)
- SWVL 0.49
- ANVS 0.26
- MACD
- SWVL 0.04
- ANVS 0.02
- Stochastic Oscillator
- SWVL 95.45
- ANVS 65.58
About SWVL Swvl Holdings Corp
Swvl Holdings Corp is a technology-driven mobility company that aims to provide reliable, safe, cost-effective and environmentally responsible mass transit solutions. It provides mobility solutions for enterprises and government and individual commuters across-multiple markets with clients such as Amazon, Bosch, E&, P&G and Siemens. The Company operates in Egypt, Saudi Arabia and the UAE.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.